We are live on ! Find out more
MKA

M. Kulyk & Associates Portfolio holdings

AUM $536M
1-Year Est. Return 18.28%
This Fund
S&P 500
This Quarter Est. Return
-6.87%
1 Year Est. Return
+18.28%
3 Year Est. Return
+52.28%
5 Year Est. Return
+66.13%
10 Year Est. Return
–
AUM
$288M
AUM Growth
-$33.7M
Cap. Flow
-$8.06M
Cap. Flow %
-2.8%
Top 10 Hldgs %
40.72%
Holding
101
New
8
Increased
43
Reduced
29
Closed
1

Top Buys

Rank Stock Value
1
LEVI icon
Levi Strauss
LEVI
+$21.3M
2
MRK icon
Merck
MRK
+$4.16M
3
LH icon
Labcorp
LH
+$2.52M
4
WSM icon
Williams-Sonoma
WSM
+$2.44M
5
STIP icon
iShares 0-5 Year TIPS Bond ETF
STIP
+$2.26M

Top Sells

Rank Stock Value
1
SPTS icon
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
+$38.4M
2
K
Kellanova
K
+$6.14M
3
CLX icon
Clorox
CLX
+$3.03M
4
NEE icon
NextEra Energy
NEE
+$2.91M
5
GIS icon
General Mills
GIS
+$2.6M

Sector Composition

Rank Sector Weight
1 Technology 19.71%
2 Consumer Discretionary 12.54%
3 Healthcare 10.23%
4 Consumer Staples 10.19%
5 Financials 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VYM icon
76
Vanguard High Dividend Yield ETF
VYM
$82.3B
$374K 0.13%
3,944
-1,289
-25% -$134K
SOFI icon
77
SoFi Technologies
SOFI
$23.5B
$366K 0.13%
74,901
– –
MMM icon
78
3M
MMM
$92.9B
$347K 0.12%
3,751
– –
PFE icon
79
Pfizer
PFE
$149B
$328K 0.11%
7,495
+3
+0% +$146
LLY icon
80
Eli Lilly
LLY
$1.04T
$313K 0.11%
969
-316
-25% -$100K
QQQ icon
81
Invesco QQQ Trust
QQQ
$483B
$310K 0.11%
1,159
– –
BE icon
82
Bloom Energy
BE
$69.5B
$303K 0.11%
15,137
– –
IEFA icon
83
iShares Core MSCI EAFE ETF
IEFA
$196B
$274K 0.1%
5,197
+22
+0.4% +$1.29K
TMO icon
84
Thermo Fisher Scientific
TMO
$214B
$274K 0.1%
541
+24
+5% +$13.4K
PYPL icon
85
PayPal
PYPL
$51B
$269K 0.09%
3,127
-33
-1% -$2.93K
SHY icon
86
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
$253K 0.09%
+3,117
New +$257K
ADBE icon
87
Adobe
ADBE
$105B
$250K 0.09%
910
-10
-1% -$3.78K
WM icon
88
Waste Management
WM
$91.5B
$244K 0.08%
1,523
– –
SUSA icon
89
iShares ESG Optimized MSCI USA ETF
SUSA
$4.17B
$243K 0.08%
3,195
– –
VGSH icon
90
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$240K 0.08%
4,146
-4,111
-50% -$241K
IBM icon
91
IBM
IBM
$220B
$233K 0.08%
1,962
– –
TFC icon
92
Truist Financial
TFC
$63.7B
$231K 0.08%
5,310
– –
AFL icon
93
Aflac
AFL
$63.3B
$224K 0.08%
3,983
+4
+0.1% +$235
SPY icon
94
State Street SPDR S&P 500 ETF Trust
SPY
$821B
$222K 0.08%
622
– –
CI icon
95
Cigna
CI
$72.8B
$214K 0.07%
+773
New +$218K
ORCL icon
96
Oracle
ORCL
$419B
$212K 0.07%
3,464
– –
WPC icon
97
W.P. Carey
WPC
$16.3B
$211K 0.07%
+3,090
New +$253K
COST icon
98
Costco
COST
$418B
$209K 0.07%
442
– –
INTC icon
99
Intel
INTC
$514B
$206K 0.07%
7,978
-10
-0.1% -$341
IAU icon
100
iShares Gold Trust
IAU
$67.7B
$205K 0.07%
6,486
-335
-5% -$11K
1 2 3
4
5

Similar funds

RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
HS
Hazelview Securities Toronto, Ontario, Canada $537M AUM 8.62% 1-Year Est. Return
BFC
Banc Funds Company Chicago, Illinois $537M AUM 17.34% 1-Year Est. Return
GC
Gibson Capital Wexford, Pennsylvania $537M AUM 14.43% 1-Year Est. Return
LIM
Lathrop Investment Management Little Rock, Arkansas $534M AUM 22.94% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
MG
Magnolia Group Omaha, Nebraska $538M AUM 5.13% 1-Year Est. Return
CM
CoreCommodity Management Stamford, Connecticut $538M AUM 71.97% 1-Year Est. Return

M. Kulyk & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, M. Kulyk & Associates held 101 positions worth $288M, down 10% from $321M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

M. Kulyk & Associates's Q3 2022 filing shows 8 new, 43 increased, 29 reduced and 1 closed positions. Its largest new stake was Merck: 46,558 shares worth $4.01M. The largest sale was State Street SPDR Portfolio Short Term Treasury ETF, an estimated $38.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • M. Kulyk & Associates's largest Q3 2022 buy was Merck: 46,558 shares worth $4.01M.
  • M. Kulyk & Associates added most to Levi Strauss in Q3 2022, an estimated $21.3M increase.
  • M. Kulyk & Associates's biggest Q3 2022 reduction was State Street SPDR Portfolio Short Term Treasury ETF, cutting an estimated $38.4M.
  • M. Kulyk & Associates fully exited Vanguard Dividend Appreciation ETF in Q3 2022, selling an estimated $510K.
  • M. Kulyk & Associates's ten largest holdings make up 41% of its $288M portfolio in Q3 2022.
  • M. Kulyk & Associates opened 8 new positions and closed 1 in Q3 2022.
  • M. Kulyk & Associates's portfolio value fell 10% quarter-over-quarter to $288M.

Based on M. Kulyk & Associates's 13F filing for Q3 2022, filed 7 Nov 2022.